The life sciences industry is primed for growth in 2024 as new life, if you will, is breathed into the industry. In New Jersey, one of the top markets nationwide for the sector, that story is playing ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck invests more than € 300 million into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck's Life ...

Merck provides 2026 and mid-term forecasts, confirms targets for 2025 Company is ready for more M&A with focus on life sciences, CEO says Shares fall after 2026 outlook announcement, after rising ...

Merck, a leading science and technology company, has opened its new $176 million filtration manufacturing facility at Blarney Business Park, Co. Cork. This site is Merck’s first manufacturing facility ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects sales ...

The low-profile developer behind a major King’s Cross life sciences scheme will push on and complete the project, even after global pharmaceutical giant Merck pulled out of the building. Merck said on ...

Narrow-moat Merck KGaA delivered solid first-quarter results, and its 2023 guidance looks in line with our expectations. To reflect cash flow generated in recent quarters, a slight increase in our ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an agreement to receive funds managed by ...